Growing community of inventors

Chicago, IL, United States of America

Arnon Lavie

Average Co-Inventor Count = 3.15

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 9

Arnon LavieManfred Konrad (3 patents)Arnon LavieJue Wang (2 patents)Arnon LavieMichael E Jung (2 patents)Arnon LavieNagichettiar Satyamurthy (2 patents)Arnon LavieJennifer Marie Murphy (2 patents)Arnon LavieCaius G Radu (2 patents)Arnon LavieDavid A Nathanson (2 patents)Arnon LavieZheng Li (2 patents)Arnon LavieRaymond M Gipson (2 patents)Arnon LavieFarhad Ravandi (2 patents)Arnon LavieHien-Anh Nguyen (2 patents)Arnon LavieAmanda Schalk (1 patent)Arnon LavieArnon Lavie (7 patents)Manfred KonradManfred Konrad (3 patents)Jue WangJue Wang (141 patents)Michael E JungMichael E Jung (77 patents)Nagichettiar SatyamurthyNagichettiar Satyamurthy (20 patents)Jennifer Marie MurphyJennifer Marie Murphy (9 patents)Caius G RaduCaius G Radu (7 patents)David A NathansonDavid A Nathanson (5 patents)Zheng LiZheng Li (3 patents)Raymond M GipsonRaymond M Gipson (3 patents)Farhad RavandiFarhad Ravandi (2 patents)Hien-Anh NguyenHien-Anh Nguyen (2 patents)Amanda SchalkAmanda Schalk (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Illinois (7 from 2,341 patents)

2. University of California (2 from 15,462 patents)

3. The United States Government As Represented by the Department of Veterans Affairs (1 from 891 patents)


7 patents:

1. 11578315 - Truncated guinea pig L-asparaginase variants and methods of use

2. 10821160 - L-asparaginase variants and fusion proteins with reduced L-glutaminase activity and enhanced stability

3. 9981961 - Deoxycytidine kinase inhibitors

4. 9598404 - Deoxycytidine kinase inhibitors

5. 8349318 - Use of specifically engineered enzymes to enhance the efficacy of prodrugs

6. 7858745 - Use of specifically engineered enzymes to enhance the efficacy of prodrugs

7. 7419811 - Use of specifically engineered enzymes to enhance the efficacy of prodrugs

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/15/2025
Loading…